Jovanovic-Talisman Lab Publications

Name: Jovanovic-Talisman Lab Publications
Keywords: Jovanovic-Talisman Lab

Mateescu B, Jones JC, Alexander RP, Alsop E, An JY, Asghari M, Boomgarden A, Bouchareychas L, Cayota A, Chang HC, Charest A, Chiu DT, Coffey RJ, Das S, De Hoff P, deMello A, D'Souza-Schorey C, Elashoff D, Eliato KR, Franklin JL, Galas DJ, Gerstein MB, Ghiran IH, Go DB, Gould S, Grogan TR, Higginbotham JN, Hladik F, Huang TJ, Huo X, Hutchins E, Jeppesen DK, Jovanovic-Talisman T, Kim BYS, Kim S, Kim KM, Kim Y, Kitchen RR, Knouse V, LaPlante EL, Lebrilla CB, Lee LJ, Lennon KM, Li G, Li F, Li T, Liu T, Liu Z, Maddox AL, McCarthy K, Meechoovet B, Maniya N, Meng Y, Milosavljevic A, Min BH, Morey A, Ng M, Nolan J, De Oliveira Junior GP, Paulaitis ME, Phu TA, Raffai RL, Reátegui E, Roth ME, Routenberg DA, Rozowsky J, Rufo J, Senapati S, Shachar S, Sharma H, Sood AK, Stavrakis S, Stürchler A, Tewari M, Tosar JP, Tucker-Schwartz AK, Turchinovich A, Valkov N, Van Keuren-Jensen K, Vickers KC, Vojtech L, Vreeland WN, Wang C, Wang K, Wang Z, Welsh JA, Witwer KW, Wong DTW, Xia J, Xie YH, Yang K, Zaborowski MP, Zhang C, Zhang Q, Zivkovic AM, Laurent LC. Phase 2 of extracellular RNA communication consortium charts next-generation approaches for extracellular RNA research. iScience. 2022 Aug 19;25(8):104653. doi: 10.1016/j.isci.2022.104653. eCollection 2022 Aug 19. Review. PubMed PMID: 35958027; PubMed Central PMCID: PMC9358052.
Jinna N, Rida P, Smart M, LaBarge M, Jovanovic-Talisman T, Natarajan R, Seewaldt V. Adaptation to Hypoxia May Promote Therapeutic Resistance to Androgen Receptor Inhibition in Triple-Negative Breast Cancer. International Journal of Molecular Sciences. 2022 August; 23(16):8844. doi: 10.3390/ijms23168844.
Lennon KM, Saftics A, Abuelreich S, Sahu P, Lehmann HI, Maddox AL, Bagabas R, Januzzi JL, Van Keuren-Jensen K, Shah R, Das S, Jovanovic-Talisman T. Cardiac troponin T in extracellular vesicles as a novel biomarker in human cardiovascular disease. Clin Transl Med. 2022 Aug;12(8):e979. doi: 10.1002/ctm2.979. PubMed PMID: 35988159.
Maddox AL, Brehove MS, Eliato KR, Saftics A, Romano E, Press MF, Mortimer J, Jones V, Schmolze D, Seewaldt VL, Jovanovic-Talisman T. Molecular Assessment of HER2 to Identify Signatures Associated with Therapy Response in HER2-Positive Breast Cancer. Cancers (Basel). 2022 Jun 4;14(11). doi: 10.3390/cancers14112795. PubMed PMID: 35681773.
Wakefield DL, Tobin SJ, Schmolze D, Jovanovic-Talisman T. Molecular Imaging of HER2 in Patient Tissues with Touch Prep-Quantitative Single Molecule Localization Microscopy. Methods Mol Biol. 2022;2394:231-248. doi: 10.1007/978-1-0716-1811-0_15. PubMed PMID: 35094332; PubMed Central PMCID: PMC9121336.
Wright N, Gong Z, Kittles R, Natarajan R, Jovanovic-Talisman T, Rida P, LaBarge M, Seewaldt V. Kinesin Family Member C1 (KIFC1/HSET): A Potential Actionable Biomarker of Early Stage Breast Tumorigenesis and Progression of High-Risk Lesions. J Pers Med. 2021 Dec 14;11(12). doi: 10.3390/jpm11121361. Review. PubMed PMID: 34945833; PubMed Central PMCID: PMC8708236.
Lennon KM, Soheilypour M, Peyro M, Wakefield DL, Choo GE, Mofrad MRK, Jovanovic-Talisman T. Characterizing Binding Interactions That Are Essential for Selective Transport through the Nuclear Pore Complex. Int J Mol Sci. 2021 Oct 8;22(19). doi: 10.3390/ijms221910898. PubMed PMID: 34639238; PubMed Central PMCID: PMC8509584.
Zhang B, Nguyen LXT, Zhao D, Frankhouser DE, Wang H, Hoang DH, Qiao J, Abundis C, Brehove M, Su YL, Feng Y, Stein A, Ghoda L, Dorrance A, Perrotti D, Chen Z, Han A, Pichiorri F, Jin J, Jovanovic-Talisman T, Caligiuri MA, Kuo CJ, Yoshimura A, Li L, Rockne RC, Kortylewski M, Zheng Y, Carlesso N, Kuo YH, Marcucci G. Treatment-induced arteriolar revascularization and miR-126 enhancement in bone marrow niche protect leukemic stem cells in AML. J Hematol Oncol. 2021 Aug 9;14(1):122. doi: 10.1186/s13045-021-01133-y. PubMed PMID: 34372909; PubMed Central PMCID: PMC8351342.
Frankhauser DE, Jovanovic-Talisman T, Lai L, Yee LD, Wang LV, Mahabal A, Geradts J, Rockne RC, Tomsic J, Jones V, Sistrunk C, Miranda-Carboni G, Dietze EC, Erhunmwunsee L, Hyslop T, Seewaldt VL. Spatiotemporal strategies to identify aggressive biology in precancerous breast biopsies. WIREs Mech Dis. 2021 Mar;13(2):e1506. doi: 10.1002/wsbm.1506. Epub 2020 Oct 1. Review. PubMed PMID: 33001587; PubMed Central PMCID: PMC8544796.
Wakefield DL, Tobin SJ, Schmolze D, Jovanovic-Talisman T. Molecular imaging of HER2 in patient tissues with touch prep-quantitative single molecule localization microscopy. In: Rasooly A, Baker H, Ossandon MR, editors. Biomedical Engineering Technologies 2 ed. New York, NY: Springer; 2021. Chapter 15;
Jones VC, Dietze EC, Jovanovic-Talisman T, McCune JS, Seewaldt VL. Metformin and Chemoprevention: Potential for Heart-Healthy Targeting of Biologically Aggressive Breast Cancer. Front Public Health. 2020;8:509714. doi: 10.3389/fpubh.2020.509714. eCollection 2020. Review. PubMed PMID: 33194937; PubMed Central PMCID: PMC7658387.
Dambal S, Alfaqih M, Sanders S, Maravilla E, Ramirez-Torres A, Galvan GC, Reis-Sobreiro M, Rotinen M, Driver LM, Behrove MS, Talisman TJ, Yoon J, You S, Turkson J, Chi JT, Freeman MR, Macias E, Freedland SJ. 27-Hydroxycholesterol Impairs Plasma Membrane Lipid Raft Signaling as Evidenced by Inhibition of IL6-JAK-STAT3 Signaling in Prostate Cancer Cells. Mol Cancer Res. 2020 May;18(5):671-684. doi: 10.1158/1541-7786.MCR-19-0974. Epub 2020 Feb 4. PubMed PMID: 32019810; PubMed Central PMCID: PMC7971119.

To view a full of list of The Talisman Lab's publications, please click to view all publications.